Cellular immunity, also known as cell-mediated immunity, is a vital component of the immune system responsible for defending the body against intracellular pathogens, abnormal cells, and various threats. Key players in cellular immunity are T lymphocytes (T cells), which are crucial for orchestrating and executing immune responses. Cellular immunity involves the recognition of antigens presented by infected or abnormal cells. Antigen-presenting cells, such as macrophages and dendritic cells, process and present antigens to T cells. This interaction activates cytotoxic T cells, which directly attack and destroy infected or abnormal cells. Helper T cells play a regulatory role by coordinating immune responses and enhancing the activity of other immune cells. Major histocompatibility complex (MHC) molecules facilitate the presentation of antigens to T cells, ensuring specificity in the immune response. Cytokines, signaling proteins released by immune cells, modulate cellular immunity, influencing the activation, proliferation, and function of T cells. Cellular immunity is crucial for eliminating viruses, intracellular bacteria, and cancer cells. Dysfunction in cellular immunity can lead to increased susceptibility to infections and the development of certain cancers. Understanding cellular immunity is essential for vaccine development, immunotherapy, and managing various immune-related disorders.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States